These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 6764658)

  • 1. Serratia marcescens: biochemical characteristics, antimicrobial sensitivity and clinical significance.
    Puthucheary SD; Ngeow YF
    Malays J Pathol; 1981 Aug; 4():35-41. PubMed ID: 6764658
    [No Abstract]   [Full Text] [Related]  

  • 2. [O-serotypes, biochemical properties and antimicrobial susceptibilities of Serratia marcescens isolated from clinical specimens (2nd report)].
    Marumo K; Takeuchi T; Aoki Y
    Rinsho Byori; 1990 Sep; 38(9):1077-82. PubMed ID: 1700174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Drug resistance of bacteria--the current status and future prospect. 4. Serratia].
    Kimura S
    Nihon Rinsho; 1984 Mar; 42(3):671-5. PubMed ID: 6381804
    [No Abstract]   [Full Text] [Related]  

  • 4. [O-serotypes, biochemical properties and antimicrobial susceptibility of Serratia marcescens isolates from clinical specimens].
    Marumo K; Aoki Y; Takeuchi T
    Rinsho Byori; 1987 May; 35(5):555-60. PubMed ID: 2441093
    [No Abstract]   [Full Text] [Related]  

  • 5. [Hospital infection due to Serratia marcescens and its sensitivity to antibiotics].
    Filloy L; Serrano D; Borjas E
    Bol Med Hosp Infant Mex; 1980; 37(5):871-7. PubMed ID: 7000092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Serratia marcescens ("B. prodigiosus"), the germ of hospital infections].
    Modde H
    Rev Med Suisse Romande; 1974 Apr; 94(4):325-32. PubMed ID: 4596928
    [No Abstract]   [Full Text] [Related]  

  • 7. Exoenzymatic characteristics and sensitivity to chemotherapeutics of Serratia marcescens. Their importance in epidemiological investigation.
    Neguţ M
    Arch Roum Pathol Exp Microbiol; 1978; 37(3-4):377-88. PubMed ID: 395929
    [No Abstract]   [Full Text] [Related]  

  • 8. Biochemical characteristics and antibiotic susceptibilities of Serratia marcescens isolated from clinical specimens.
    Chong Y; Yi KN; Lee SY
    Yonsei Med J; 1978; 19(1):32-8. PubMed ID: 382648
    [No Abstract]   [Full Text] [Related]  

  • 9. [Urinary tract infections due to Serratia marcescens. I. Antimicrobial susceptibility patterns of clinical isolates of Serratia marcescens (author's transl)].
    Igari J; Kosakai N
    Jpn J Antibiot; 1977 Oct; 30(10):840-6. PubMed ID: 338940
    [No Abstract]   [Full Text] [Related]  

  • 10. SME-2-producing Serratia marcescens isolate from Switzerland.
    Poirel L; Wenger A; Bille J; Bernabeu S; Naas T; Nordmann P
    Antimicrob Agents Chemother; 2007 Jun; 51(6):2282-3. PubMed ID: 17420208
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical studies on urinary tract infections caused by Serratia marcescens. I. Clinical and bacteriological studies on urinary tract infections caused by Serratia marcescens].
    Sakai S; Kumamoto Y
    Nihon Hinyokika Gakkai Zasshi; 1983 Apr; 74(4):467-84. PubMed ID: 6353020
    [No Abstract]   [Full Text] [Related]  

  • 12. Serratia marcescens: use of detailed characterization of strains to evaluate an increase of isolates in an intensive care unit.
    Cardos SF; Florman AL; Simberkoff MS; Lanier L
    Am J Med Sci; 1973 Dec; 266(6):447-52. PubMed ID: 4590096
    [No Abstract]   [Full Text] [Related]  

  • 13. Activity of eight aminoglycosides against isolates of Serratia marcescens from four hospitals.
    Verbist L; Vandepitte J; Vandeven J
    J Antimicrob Chemother; 1978 Jan; 4(1):47-55. PubMed ID: 342482
    [No Abstract]   [Full Text] [Related]  

  • 14. [Serratia marcescens isolated from clinical specimens in recent years].
    Nishino K; Kuze T; Kuroda C; Mizunoya T
    Rinsho Byori; 1982 Sep; 30(9):1029-32. PubMed ID: 6757494
    [No Abstract]   [Full Text] [Related]  

  • 15. [Epidemiological evaluation of Serratia marcescens isolates in one Japanese hospital during the two years from April 1997 to March 1999].
    Marumo K; Nakamura Y; Togashi M
    Rinsho Byori; 2000 Oct; 48(10):960-5. PubMed ID: 11215111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of R factors in Serratia marcescens strains isolated from the "Hospital Universitario de Caracas".
    Rodríguez Lemoine V; de Ramírez Y; Pedroza R
    Acta Cient Venez; 1983; 34(3-4):228-32. PubMed ID: 6399968
    [No Abstract]   [Full Text] [Related]  

  • 17. [Study on Serratia marcesceus; biochemical behavior of marcesceus strains and sensitivity to antimicrobials].
    Domínguez Rojas V; Ales JM; Soriano García F
    Rev Clin Esp; 1977 May; 145(4):265-9. PubMed ID: 325609
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical aspects of urinary tract infection by Serratia marcescens].
    Miyakita H; Kawashima T; Kinoshita H; Kawamura N
    Hinyokika Kiyo; 1984 Feb; 30(2):153-8. PubMed ID: 6377857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serratia marcescens isolated in 2005 from clinical specimens from patients with diminished immunity.
    Młynarczyk A; Młynarczyk G; Pupek J; Bilewska A; Kawecki D; Łuczak M; Gozdowska J; Durlik M; Paczek L; Chmura A; Rowińnski W
    Transplant Proc; 2007 Nov; 39(9):2879-82. PubMed ID: 18022007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transfer of antimicrobial resistance in Serratia marcescens.
    Bhujwala RA; Shriniwas ; Dutta S
    Indian J Med Res; 1984 Jan; 79():22-7. PubMed ID: 6373583
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.